Venus Concept Inc. (VERO)

Market Cap	5.34M
Revenue (ttm)	76.35M
Net Income (ttm)	-37.25M
Shares Out	6.36M
EPS (ttm)	-6.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,946
Open	0.740
Previous Close	0.775
Day's Range	0.740 - 0.900
52-Week Range	0.602 - 4.700
Beta	0.58
Analysts	Hold
Price Target	n/a
Earnings Date	May 15, 2024

About VERO

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF ...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Rajiv Kanishka Liyanaarchchie De Silva
• Employees: 304
• Stock Exchange: NASDAQ
• Ticker Symbol: VERO

Financial Performance

In 2023, Venus Concept's revenue was $76.35 million, a decrease of -23.26% compared to the previous year's $99.50 million. Losses were -$37.25 million, -14.76% less than in 2022.